DISCOUNT-ZERTIFIKAT - PFIZER INC Stock

Certificat

DE000HC8R8V7

Real-time BOERSE MUENCHEN 07:46:58 2024-07-17 am EDT
23.95 EUR -0.46% Intraday chart for DISCOUNT-ZERTIFIKAT - PFIZER INC
Current month+0.97%
1 month+2.08%
Date Price Change
24-07-17 23.95 -0.46%
24-07-16 24.06 +0.38%
24-07-15 23.97 +0.38%
24-07-12 23.88 +0.46%
24-07-11 23.77 +0.13%

Real-time BOERSE MUENCHEN

Last update July 17, 2024 at 07:46 am EDT

More quotes

Static data

Product typeCertificati Discount
Buy / SellCALL
Underlying PFIZER, INC.
IssuerLogo Issuer UniCredit UniCredit
WKN HC8R8V
ISINDE000HC8R8V7
Date issued 2023-08-16
Maturity 2024-12-20 (156 Days)
Parity 1 : 1
Emission price 23.4
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 24.06
Lowest since issue 20.77
Spread 0.02
Spread %0.08%

Company Profile

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
More about the company

Ratings for Pfizer, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Pfizer, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
29.5 USD
Average target price
32.1 USD
Spread / Average Target
+8.80%
Consensus